Felis consequat magnis est fames sagittis ultrices placerat sodales porttitor quisque.
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…
Media365Shenzhen’s residential inventory has fallen to a seven-year low, putting the southern technology hub ahead of other first-tier Chinese cities in clearing excess housing stock – a condition investors see…
Media365Amid geopolitical tensions, China’s Tianqi Lithium has decided to skip Africa and will stick to domestic salt lakes to secure the supply of a battery mineral, according to its president…
